Ashiq Mubarack

Stock Analyst at Citigroup

(2.15)

# 2,557

Out of 4,722 analysts

3

Total ratings

66.67%

Success rate

4.52%

Average return

Main Sectors:

Top Industries:

Stocks Rated by Ashiq Mubarack

	Stock	Action	Price Target	Current	Upside	Ratings	Updated
	MRSN Mersana Therapeutics	Maintains: Buy	$6 → $5	$1.37	+264.96%	2	Aug 27, 2024
	DRTS Alpha Tau Medical	Initiates: Buy	$8	$3.35	+138.81%	1	Dec 15, 2023

Mersana Therapeutics

Aug 27, 2024

Maintains: Buy

Price Target: $6 → $5

Current: $1.37

Upside: +264.96%

Alpha Tau Medical

Dec 15, 2023

Initiates: Buy

Price Target: $8

Current: $3.35

Upside: +138.81%